# Study to Evaluate the Effects of NMRA-323511 Among Healthy Elderly and Adults With Agitation Associated With Dementia Due to Alzheimer's Disease

> **NCT06546995** · PHASE1 · COMPLETED · sponsor: **Neumora Therapeutics, Inc.** · enrollment: 96 (actual)

## Conditions studied

- Alzheimer's Disease
- Healthy Elderly

## Interventions

- **DRUG:** NMRA-323511
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06546995
- **Lead sponsor:** Neumora Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-07-09
- **Primary completion:** 2025-11-19
- **Final completion:** 2025-11-19
- **Target enrollment:** 96 (ACTUAL)
- **Last updated:** 2025-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06546995

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06546995, "Study to Evaluate the Effects of NMRA-323511 Among Healthy Elderly and Adults With Agitation Associated With Dementia Due to Alzheimer's Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06546995. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*